Showing results (741-750 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|May 1, 1975
Plasma testosterone levels during chronic heroin use and protracted astinence. A study of Hong Kong addictsJ H Mendelson, N K MelloClinical Pharmacology and Therapeutics|May 1, 1975
Respiratory effects of delta-9-tetrahydrocannabinolJ W Bellville, G D Swanson, K A AqlehClinical Pharmacology and Therapeutics|May 1, 1975
First-pass metabolism of imipramine in manL F Gram, J ChristiansenClinical Pharmacology and Therapeutics|May 1, 1975
Pharmacokinetic studies of tolmetin in manM L Selley, J Glass, E J Triggs, et al.Clinical Pharmacology and Therapeutics|December 26, 2001
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive diseaseC Joukhadar, N Klein, M Frossard, et al.Clinical Pharmacology and Therapeutics|December 26, 2001
QT interval lengthening in premature infants treated with doxapramC Maillard, M J Boutroy, J Fresson, et al.Clinical Pharmacology and Therapeutics|December 26, 2001
Association of polymorphism in the cytochrome CYP2D6 and the efficacy and tolerability of simvastatinA B Mulder, H J van Lijf, M A Bon, et al.Clinical Pharmacology and Therapeutics|November 4, 2000
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"D S Streetman, J F Bleakley, J S Kim, et al.Clinical Pharmacology and Therapeutics|November 4, 2000
In vivo modulation of CYP enzymes by quinidine and rifampinR A Branch, A Adedoyin, R F Frye, et al.Clinical Pharmacology and Therapeutics|November 4, 2000
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headachesJ N de Hoon, J M Willigers, J Troost, et al.Pageof 941